Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bosentan for High Risk Staged Fontan Procedure
NCT01662037Phase 2Completed
- Sponsor
- Shanghai Jiao Tong University School of Medicine
- Start
- Jan 2010
- Primary completion
- Sep 2011
- Modality
- Nucleic Acid-Directed Small Molecules, Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of bosentan in univentricular heart (UVH) (2 arms), sponsored by Shanghai Jiao Tong University School of Medicine. Primary endpoint: Length of hospital stay and ICU stay. Started Jan 2010; status: completed.
02
Drugs
bosentan
03
Conditions
univentricular heart (UVH)
Beyond the preview
Go deeper on NCT01662037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01662037.